BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 26838548)

  • 1. ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling.
    Wang J; Rouse C; Jasper JS; Pendergast AM
    Sci Signal; 2016 Feb; 9(413):ra12. PubMed ID: 26838548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
    Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
    J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone metastatic process of breast cancer involves methylation state affecting E-cadherin expression through TAZ and WWOX nuclear effectors.
    Matteucci E; Maroni P; Luzzati A; Perrucchini G; Bendinelli P; Desiderio MA
    Eur J Cancer; 2013 Jan; 49(1):231-44. PubMed ID: 22717556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
    Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
    Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SREBP-2 aggravates breast cancer associated osteolysis by promoting osteoclastogenesis and breast cancer metastasis.
    Jie Z; Xie Z; Xu W; Zhao X; Jin G; Sun X; Huang B; Tang P; Wang G; Shen S; Qin A; Fan S
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):115-125. PubMed ID: 30394316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface.
    Nannuru KC; Futakuchi M; Varney ML; Vincent TM; Marcusson EG; Singh RK
    Cancer Res; 2010 May; 70(9):3494-504. PubMed ID: 20406980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway.
    Li XQ; Du X; Li DM; Kong PZ; Sun Y; Liu PF; Wang QS; Feng YM
    Cancer Res; 2015 Aug; 75(16):3302-13. PubMed ID: 26060017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Is Breast in the Bone?
    Shemanko CS; Cong Y; Forsyth A
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
    Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
    Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalization of MMP9 and MMP2 in osteolytic metastasis originating from MDA-MB-231 human breast cancer cells.
    Liu B; Cui J; Sun J; Li J; Han X; Guo J; Yi M; Amizuka N; Xu X; Li M
    Mol Med Rep; 2016 Aug; 14(2):1099-106. PubMed ID: 27278284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-species analysis of a mouse model of breast cancer-specific osteolysis and human bone metastases using gene expression profiling.
    Sadanandam A; Futakuchi M; Lyssiotis CA; Gibb WJ; Singh RK
    BMC Cancer; 2011 Jul; 11():304. PubMed ID: 21774828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. δEF1 promotes osteolytic metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
    Hu F; Wang C; Guo S; Sun W; Mi D; Gao Y; Zhang J; Zhu T; Yang S
    Biochim Biophys Acta; 2011 Mar; 1809(3):200-10. PubMed ID: 21241837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells.
    Nakata A; Tsujimura T; Sugihara A; Okamura H; Iwasaki T; Shinkai K; Iwata N; Kakishita E; Akedo H; Terada N
    Anticancer Res; 1999; 19(5B):4131-8. PubMed ID: 10628364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory roles of miRNAs 16, 133a, and 223 on osteoclastic bone destruction caused by breast cancer metastasis.
    Kitayama K; Kawamoto T; Kawakami Y; Hara H; Takemori T; Fujiwara S; Yahiro S; Miyamoto T; Mifune Y; Hoshino Y; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Kuroda R; Akisue T
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34713296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone.
    Gordon AH; O'Keefe RJ; Schwarz EM; Rosier RN; Puzas JE
    Cancer Res; 2005 Apr; 65(8):3209-17. PubMed ID: 15833852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone.
    Bellanger A; Donini CF; Vendrell JA; Lavaud J; Machuca-Gayet I; Ruel M; Vollaire J; Grisard E; Győrffy B; Bièche I; Peyruchaud O; Coll JL; Treilleux I; Maguer-Satta V; Josserand V; Cohen PA
    J Pathol; 2017 May; 242(1):73-89. PubMed ID: 28207159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
    Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
    Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Visfatin-Promoted Malignant Behavior in Breast Cancer Is Mediated Through c-Abl and STAT3 Activation.
    Hung AC; Lo S; Hou MF; Lee YC; Tsai CH; Chen YY; Liu W; Su YH; Lo YH; Wang CH; Wu SC; Hsieh YC; Hu SC; Tai MH; Wang YM; Yuan SS
    Clin Cancer Res; 2016 Sep; 22(17):4478-90. PubMed ID: 27036136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis.
    Wang J; Du X; Wang X; Xiao H; Jing N; Xue W; Dong B; Gao WQ; Fang YX
    Cancer Lett; 2022 Feb; 526():76-90. PubMed ID: 34801597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.